window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

nephrology

  • Biologics & Biosimilars,Clinical Development,Clinical Trials,Drug Development,Medical devices,Pharmaceuticals and therapeutics,Research & Development

    Xeltis reports positive EU key trial results for aXess, showing superior patency and safety in hemodialysis

    Xeltis’ aXess EU key trial shows sustained patency, fewer interventions, [...]

    October 2, 2025
  • Biologics & Biosimilars,Chronic diseases,Clinical Development,Clinical Trials,Drug Development,Global health,Medical devices,Pharmaceuticals and therapeutics,Regulatory Affairs

    Hansa Biopharma reports statistically significant improvement in kidney function, supporting planned BLA submission

    Hansa Biopharma AB has announced positive topline results from the [...]

    September 26, 2025
  • Biologics & Biosimilars,Biotech,Clinical Trials,Medical devices,Oncology,Pharmaceuticals and therapeutics,Technology and platforms

    Xeltis poised for commercialization following positive EU pivotal trial results

    Xeltis has announced successful clinical data from its aXess EU [...]

    September 26, 2025
  • Uncategorised

    FDA clears Daxor’s next-generation blood volume analyzer for precise fluid management

    Daxor Corporation, a global leader in blood volume measurement technology, [...]

    August 8, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top